PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20015241-2	2010	Increased concentration of hepatocyte growth factor (HGF) is associated with poor prognosis in patients treated with conventional chemotherapy or thalidomide.	Thalidomide	146-157	hepatocyte growth factor	Homo sapiens	27-51	
20015241-2	2010	Increased concentration of hepatocyte growth factor (HGF) is associated with poor prognosis in patients treated with conventional chemotherapy or thalidomide.	Thalidomide	146-157	hepatocyte growth factor	Homo sapiens	53-56	
15149630-1	2004	Thalidomide has antiangiogenic and immunomodulatory effects, mediated by several cytokines such as vascular endothelial growth factor (VEGF), fibroblastic growth factor (FGF-2), hepatocyte growth factor (HGF), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha).	Thalidomide	0-11	hepatocyte growth factor	Homo sapiens	178-202	
15149630-1	2004	Thalidomide has antiangiogenic and immunomodulatory effects, mediated by several cytokines such as vascular endothelial growth factor (VEGF), fibroblastic growth factor (FGF-2), hepatocyte growth factor (HGF), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha).	Thalidomide	0-11	hepatocyte growth factor	Homo sapiens	204-207